In a filing, Vertex Pharmaceuticals, Inc. revealed its Director Bhatia Sangeeta N. unloaded Company’s shares for reported $0.19 million on May 02 ’24. In the deal valued at $402.95 per share,467 shares were sold. As a result of this transaction, Bhatia Sangeeta N. now holds 4,435 shares worth roughly $1.78 million.
Then, Ambrose Kristen sold 240 shares, generating $100,560 in total proceeds. Upon selling the shares at $419.00, the SVP & Chief Accounting Officer now owns 7,500 shares.
Before that, Arbuckle Stuart A sold 5,034 shares. Vertex Pharmaceuticals, Inc. shares valued at $2,142,974 were divested by the EVP, COO at a price of $425.70 per share. As a result of the transaction, Arbuckle Stuart A now holds 49,691 shares, worth roughly $19.93 million.
Evercore ISI upgraded its Vertex Pharmaceuticals, Inc. [VRTX] rating to an Outperform from a an In-line in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Evercore ISI also remained covering VRTX and has decreased its forecast on February 06, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. Bernstein revised its rating on February 02, 2024. It rated VRTX as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc. [NASDAQ:VRTX] saw its stock jump 0.23% to $401.08. Over the last five days, the stock has gained 0.91%. Vertex Pharmaceuticals, Inc. shares have fallen nearly -1.43% since the year began. Nevertheless, the stocks have risen 15.80% over the past one year. While a 52-week high of $448.40 was reached on 01/30/24, a 52-week low of $320.01 was recorded on 04/18/24. SMA at 50 days reached $409.30, while 200 days put it at $384.61. A total of 1.06 million shares were traded, compared to the trading of 1.05 million shares in the previous session.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 397.22, which if violated will result in even more drops to 393.37. On the upside, there is a resistance level at 405.30. A further resistance level may holdings at 409.52. The Relative Strength Index (RSI) on the 14-day chart is 48.64, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.40, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 36.83%. Stochastics %K at 63.47% indicates the stock is a holding.
